Pharmafile Logo
Pharmafocus logo
Advanced Search

From surgery to pharmacy

October 12, 2006
Sales and Marketing P, POM, marketing, reclassification, sales

Feature

Pfizer buys British vaccine company PowderMed

October 12, 2006
Research and Development Pfizer, Powdermed, vaccines

Pfizer will gain entry into the fast-growing vaccines market by buying PowderMed, the British company developing next generation products in …

News

Alzheimer’s drug ruling ”a terrible decision”

October 11, 2006
Sales and Marketing

Campaigners are stunned at NICE's final decision not to allow Alzheimer's drugs to be prescribed on the NHS in the …

News

Takeda retains The Remedy for European events

October 6, 2006
Medical Communications

Takeda Europe has re-appointed marketing firm The Remedy to run its pan-European and international meetings for 2007.The Remedy, which is …

News

Amgen to acquire Avidia

October 5, 2006
Research and Development, Sales and Marketing

Amgen is to pay $290 million to buy Avidia, a Californian biotech company which is developing innovative new protein-based medicines.Based …

News

General practice reaps rewards of contract

October 2, 2006

GPs and patients are continuing to reap the rewards of the new general practice contract, with doctors hitting targets for …

News

Novartis’ MS drug shows further promise

October 2, 2006
Research and Development

A new treatment for multiple sclerosis currently being developed by Novartis has shown further promise in slowing the progress of …

News

Transparently beneficial?

October 2, 2006
Medical Communications, Sales and Marketing industry relations, key opinion leaders, pharma

The pharma industry is under greater pressure than ever before to adopt an acceptable and ethical way of doing business, …

Feature

Pharmacists unhappy with Pfizer’s new UK supply chain

September 29, 2006
Manufacturing and Production

Pfizer has announced a radical overhaul of how it distributes its medicines to community pharmacists and dispensing doctors in the …

News

Novartis submits next generation blood pressure drug

September 29, 2006
Sales and Marketing

Next generation hypertension drug Rasilez has been submitted for EU approval.If approved, Rasilez will be the first ever renin inhibitor, …

News

Two new AstraZeneca laboratories opened in UK

September 29, 2006
Research and Development

AstraZeneca has officially opened two major research laboratories in the UK, which it says demonstrates its commitment to R&D in …

News

GSK scores partial victory over parallel traders

September 29, 2006
Manufacturing and Production

GlaxoSmithKline has won a partial but significant victory in a European Union court which could give it and other pharma …

News

Three innovative medicines win Prix Galien awards

September 27, 2006
Sales and Marketing prix galien

Three pharmaceutical products have been awarded prizes at this year’s UK Prix Galien awards, which recognise excellence in pharmaceutical development …

News

UCB to buy Schwarz Pharma for 4 billion euros

September 26, 2006
Sales and Marketing

Belgian pharma company UCB is to buy Germany's Schwarz Pharma for 4.4 billion euros, creating a new mid-sized group with …

News

Noxafil close to approval for invasive fungal infections

September 25, 2006
Sales and Marketing

Schering-Plough's Noxafil is set to gain European approval for patients at high risk of developing invasive fungal infections.These infections can …

News

GSK gambles on success of new European pricing deal

September 25, 2006
Sales and Marketing EU, GSK

GlaxoSmithKline has unveiled a new deal which could break the deadlock over the pricing of medicines in Europe.The groundbreaking agreement …

News

Gardasil approved in Europe

September 22, 2006
Sales and Marketing Gardasil

Sanofi Pasteur MSD's Gardasil has been approved as the first ever vaccine to prevent women developing cervical cancer, which remains …

News

Specialist pharma company Nycomed buys Altana

September 22, 2006
Sales and Marketing Nycomed

Danish speciality pharmaceutical company Nycomed is to acquire pharma company Altana for 4.5 billion euros.Germany's Altana is currently a business …

News

New diabetes drug Byetta set for European approval

September 22, 2006
Sales and Marketing Byetta, diabetes

Lilly and Amylin's new diabetes treatment Byetta is set for European approval following recommendation from medicines regulator the EMEA.Byetta (exenatide) …

News

Merck to buy Serono for $13 billion

September 22, 2006
Sales and Marketing Merck Serono

German pharma company Merck is to acquire Serono for $13.5 billion, creating one of Europes largest bio-pharmaceutical technology companies.The new …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026